Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice

Fig. 3

Bland–Altman plots comparing tumor uptake of [18F]FDG (A, B) and [89Zr]Zr-DFO-NCS-trastuzumab (C, D) assessed by PET imaging (PET/CT: A, C; PET/MR: B, D) or by ex vivo biodistribution. The middle-dotted line shows the Bias (mean of the ratios) and the upper and lower dotted lines show the 95% limits of agreement. Average (%IA/g) corresponds to the average uptake value per animal between PET and ex vivo biodistribution

Back to article page